Skip to content
PICO Portalanswers from OpenAlex

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe

PaperCitations, authors & open-access status

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe is a paper indexed in PICO Portal from OpenAlex.

How many citations does Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe have?

PICO Portalcitation count

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe has 6 citations in the OpenAlex counts PICO Portal stores.

When was Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe published?

PICO Portalyear

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe has 2023 year in the PICO Portal index.

What is the open-access status of Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe?

PICO Portaloa status

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe has hybrid oa status in the PICO Portal index.

What is the DOI of Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe?

PICO Portaldoi

The DOI for Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe is on the source record.

What is the PMID of Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe?

PICO Portalpmid

The PMID for Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe is on the source record.

What is the OpenAlex record for Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe?

PICO Portalopenalex

The OpenAlex for Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial